Results 151 to 160 of about 531,192 (386)
Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease
ABSTRACT Objective Freezing of gait (FOG) in people with Parkinson's disease (PwPD) is debilitating and has limited treatments. Modafinil modulates beta/gamma band activity in the pedunculopontine nucleus (PPN), like PPN deep brain stimulation. We therefore tested the hypothesis that Modafinil would improve FOG in PwPD.
Tuhin Virmani +8 more
wiley +1 more source
Case Report: Surgical management of medial collateral ligament calcification
Calcification is a self-limiting disease, characterized by the deposition of calcium, causing severe pain, swelling, and movement disorder. It is mainly found in the shoulder joint but has also been reported in other joints such as the wrist, hip, knee ...
Yihang You +3 more
doaj +1 more source
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah +5 more
wiley +1 more source
Understanding the controls behind the calcification and distribution of planktonic foraminifera in the modern ocean is important when these organisms are used for palaeoceanographic reconstructions. This study combines previously reported shell mass data
Stergios D. Zarkogiannis
doaj +1 more source
Objective The objective was to identify factors determining acute arthritis resolution and safety with colchicine and prednisone in acute calcium pyrophosphate (CPP) crystal arthritis. Methods We conducted a post hoc analysis of the COLCHICORT trial, which compared colchicine and prednisone for the treatment of acute CPP crystal arthritis, using a ...
Tristan Pascart +14 more
wiley +1 more source
Echinococcal disease in Alberta, Canada: more than a calcified opacity [PDF]
Ali M. Somily +4 more
openalex +1 more source
Objective There are no US Food and Drug Administration–approved therapies for Raynaud phenomenon (RP) in the United States. Clinical trials have been challenged by study design. Important advances in RP patient‐reported outcome measures and mechanistic quantification allow RP‐related pain characterization.
Tracy M. Frech +4 more
wiley +1 more source
Spontaneous calcification process in primary renal cells from a medullary sponge kidney patient harbouring a
Federica Mezzabotta +9 more
openalex +1 more source

